Navigation Links
Actavis Receives Approval of Levetiracetam Oral Solution in the U.S.
Date:1/21/2009

MORRISTOWN, N.J., Jan. 21 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Levetiracetam Oral Solution. Distribution of the product has commenced.

Levetiracetam Oral Solution is available in the 100mg/mL strength and is the generic equivalent of Keppra(R) Oral Solution by UCB, Incorporated. Levetiracetam Oral Solution is used in the treatment of partial onset seizures in adults and children with epilepsy. Annual U.S. sales of Keppra(R) Oral Solution were US$95.9 million for the 12 months ending September 2008 according to IMS Health data.

Commenting on the new approval, Doug Boothe, CEO of Actavis in the United States said:

"The approval of Levetiracetam Oral Solution demonstrates our continuing commitment to introduce new generic products to the marketplace, as well as highlights our expertise in developing and manufacturing a wide range of dosage forms. Actavis' drive to be a leader in generic pharmaceuticals is supported by one of the largest product development pipelines in the industry. "

About Actavis

Actavis is one of the world's leading generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals. With headquarters in Iceland, Actavis has operations in 40 countries, with 11,000 employees. The United States is the company's single largest market. Actavis' U.S. operations are located in New Jersey, Maryland, North Carolina and Florida.

More information about Actavis in the United States can be found at www.actavis.us.

Information in this press release may contain forward-looking statements with respect to the financial condition, results of operations and businesses of Actavis. By
'/>"/>

SOURCE Actavis Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S.
2. Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S.
3. Harvard Business School Publishes a Case Study on Robert Wessman and Actavis
4. Actavis Extends Portfolio With Four New Products in the U.S.
5. Actavis Confirms its Patent Challenge of Kings Avinza(R)
6. Actavis Launches Amlodipine Tablets in the U.S.
7. Actavis Launches Carvedilol Tablets in the U.S.
8. Horphag Research Receives 2008 Frost & Sullivan North American Health Ingredients Excellence In Research Award
9. Samplify Systems Receives Top Honors From Electronic Products and EDN Magazines
10. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
11. Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... in those who listened just a few hours a day ... for a few hours a day can help boost a ... study of 54 patients who,d suffered a stroke of the ... who listened to music for a few hours a day ...
... Does exposure of baby boys -- in utero or in ... natural estrogens, predispose them to prostate cancer later in life? ... Illinois at Chicago researcher and her colleague aims to answer ... it may occur. , Gail Prins, professor of urology at ...
... This release is available in French . , ... battle in the fight against age-related macular degeneration, or AMD, ... international team, led by researchers at Sainte-Justine Hospital and the ... the dry form of AMD. , In the February ...
... an active material could be used to remove toxic ... much more effectively and at lower cost than conventional ... current issue of the International Journal of Nanotechnology. , ... Wark Research Institute, at the University of South Australia, ...
... Feb. 20 HIV/AIDS is still a,taboo topic among ... to change this. For Dinah Ayna, talking about HIV ... is a challenging, yet a rewarding,part of her daily ... are 3.5 million Arab,Americans in the U.S. One-third live ...
... 20 LifeSync Corporation is,pleased to announce the ... of Research and Development. Dr. Phelps, who will ... responsible for leading all,product design and development at ... Georgia Electronic Design Center (GEDC),at the Georgia Institute ...
Cached Medicine News:Health News:Music Therapy Improves Stroke Outcomes 2Health News:Grant to study if early BPA exposure leads to late prostate cancer 2Health News:AMD discovery: New hope for treatment of vision loss 2Health News:Cleaner water through nanotechnology 2Health News:Breaking Down Barriers: A Woman's Path to Reducing HIV Stigma in the Arab American Community 2Health News:LifeSync Hires Dr. Mark Phelps to Lead Research & Development 2
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Cardiac Science Corporation (Nasdaq: CSCX ), a ... ) and diagnostic cardiac monitoring devices, announced today it appointed ... of directors. Andrews replaces long-time board member Jue-Hsien Chern, Ph.D., ... The total number of directors remains at six. , ...
... (Nasdaq: ITMN ) today announced results from operations for the ... InterMune reported a net loss for the third quarter of ... net loss of $14.0 million, or $0.36 per share, in the ... and President of InterMune, said, "The third quarter and recent weeks ...
Cached Medicine Technology:Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 3Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 4Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 13
... The Nightingale Monitoring System™ expands hospital-grade monitoring ... of subacute care and disease state management. ... ability to encompass a full range of ... patients inside the hospital, to periodic monitoring ...
... FlexNet adds wireless capability to ... This expands the Flexible Monitoring concept ... patient information from anywhere to anywhere. ... ambulatory wireless monitors and hardwired and ...
... Propaq CS makes the ... Propaq CS even more ... Symbol Technologies, the Wireless ... wireless ethernet Local Area ...
... Welch Allyn Vital Signs Monitor ... clinical areas that don't require ... to use, each monitor comes ... and optional features include Nellcor ...
Medicine Products: